Form 4: Akoya Biosciences Executive Jennifer Kamocsay Reports Stock Transactions
SEC Form 4 Filing
Jennifer Kamocsay, Chief Legal Officer of Akoya Biosciences, reports the withholding of shares to cover taxes on restricted stock unit awards.
Summary
- On March 1, 2025, Jennifer Kamocsay, Chief Legal Officer of Akoya Biosciences, Inc., had shares of common stock withheld to cover taxes related to previously granted restricted stock unit (RSU) awards.
- A total of 3,851 shares were withheld at a price of $1.63 per share related to an RSU award granted on March 20, 2023.
- An additional 3,594 shares were withheld at a price of $1.63 per share related to an RSU award granted on February 22, 2024.
- Following these transactions, Kamocsay directly owns 179,272 shares of Akoya Biosciences common stock.
Sentiment
Score: 5
Explanation: This is a neutral report on stock transactions related to executive compensation. It doesn't inherently indicate positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure related to executive compensation and does not necessarily indicate a significant trend in the company's performance or outlook.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders, as they relate to tax obligations of an executive.
Key Dates
| Date | Description |
|---|---|
| March 20, 2023 | Date of original restricted stock unit award that vests in four equal annual installments beginning on March 1, 2024. |
| February 22, 2024 | Date of original restricted stock unit award that vests in four equal annual installments beginning on March 1, 2025. |
| March 1, 2024 | First vesting date of the March 20, 2023 restricted stock unit award. |
| March 1, 2025 | Date of stock transactions (tax withholding) and first vesting date of the February 22, 2024 restricted stock unit award. |
| March 4, 2025 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.